Cargando…
Asthma may not be a risk factor for severe COVID-19 in children
Autores principales: | Amat, Flore, Delaisi, Bertrand, Labbé, Jean-Philippe, Leonardi, Jacques, Houdouin, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055445/ https://www.ncbi.nlm.nih.gov/pubmed/33852880 http://dx.doi.org/10.1016/j.jaip.2021.03.046 |
Ejemplares similares
-
Predicting the Long-Term Course of Asthma in Wheezing Infants Is Still a Challenge
por: Amat, Flore, et al.
Publicado: (2011) -
COVID-19 infection may trigger poor asthma control in children
por: Chou, Christine C., et al.
Publicado: (2022) -
Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
por: Lambert, Nathalie, et al.
Publicado: (2015) -
Determinants of Allergic Rhinitis in Young Children with Asthma
por: Moussu, Lise, et al.
Publicado: (2014) -
Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
por: Just, Jocelyne, et al.
Publicado: (2020)